Combination of Fundal Height and Ultrasound to Predict Small for Gestational Age at Birth.
Journal
American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
pmc-release:
01
01
2024
pubmed:
4
5
2021
medline:
4
1
2023
entrez:
3
5
2021
Statut:
ppublish
Résumé
The objective of the study was to determine whether adding longitudinal measures of fundal height (FH) to the standard cross-sectional FH to trigger third trimester ultrasound estimated fetal weight (EFW) would improve small for gestational age (SGA) prediction. We developed a longitudinal FH calculator in a secondary analysis of a prospective cohort study of 1,939 nonobese pregnant women who underwent serial FH evaluations at 12 U.S. clinical sites. We evaluated cross-sectional FH measurement ≤ -3 cm at visit 3 (mean: 32.0 ± 1.6 weeks) versus the addition of longitudinal FH up to and including visit 3 to trigger an ultrasound to diagnose SGA defined as birth weight <10th percentile. If the FH cut points were not met, the SGA screen was classified as negative. If FH cut points were met and EFW was <10th percentile, the SGA screen was considered positive. If EFW was ≥10th percentile, the SGA screen was also considered negative. Sensitivity, specificity, and positive predictive value (PPV) and negative predictive value (NPV) were computed. In a comparison of methods, 5.8% of women were classified as at risk of SGA by both cross-sectional and longitudinal classification methods; cross-sectional FH identified an additional 4.0%, and longitudinal fundal height identified a separate, additional 4.5%.Using cross-sectional FH as an ultrasound trigger, EFW had a PPV and NPV for SGA of 69 and 92%, respectively. After adding longitudinal FH, PPV increased to 74%, whereas NPV of 92% remained unchanged; however, the number of women who underwent triggered EFW decreased from 9.7 to 5.7%. An innovative approach for calculating longitudinal FH to the standard cross-sectional FH improved identification of SGA birth weight, while simultaneously reducing the number of triggered ultrasounds. As an essentially free-of-charge screening test, our novel method has potential to decrease costs as well as perinatal morbidity and mortality (through better prediction of SGA). · We have developed an innovative calculator for fundal height trajectory.. · Longitudinal fundal height improves detection of SGA.. · As a low cost screening test, the fundal height calculator may decrease costs and morbidity through better prediction of SGA..
Identifiants
pubmed: 33940642
doi: 10.1055/s-0041-1728837
pmc: PMC8802337
mid: NIHMS1758860
doi:
Banques de données
ClinicalTrials.gov
['NCT00912132']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-162Subventions
Organisme : Intramural NIH HHS
ID : Z99 HD999999
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800002C
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800013C
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800003I
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800003C
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275201000009C
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800014C
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800002I
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800028C
Pays : United States
Organisme : NICHD NIH HHS
ID : HHSN275200800012C
Pays : United States
Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
D.A.W. has been a consultant for Parsagen, for which she received no compensation. She was formerly Professor of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine at University of California, Irvine during time of data collection. She is currently Senior Client Partner at Korn Ferry, Los Angeles, California. At the time of manuscript development, S.J.P. was a postdoctoral fellow at NICHD, and she is currently an employee of Pfizer, Inc, Collegeville, PA. The other authors did not report any potential conflicts of interest.
Références
Eur J Obstet Gynecol Reprod Biol. 1997 Mar;72(1):3-8
pubmed: 9076414
Am J Perinatol. 2014 Mar;31(3):187-94
pubmed: 23592315
Int J Epidemiol. 2018 Feb 1;47(1):25-25l
pubmed: 29025016
Obstet Gynecol. 2007 Oct;110(4):892-9
pubmed: 17906025
Am J Obstet Gynecol. 2015 Oct;213(4):449.e1-449.e41
pubmed: 26410205
Am J Perinatol. 2017 Mar;34(4):409-414
pubmed: 27627793
BJOG. 2015 Mar;122(4):518-27
pubmed: 25346493
Am J Obstet Gynecol. 1985 Feb 1;151(3):333-7
pubmed: 3881966
Obstet Gynecol. 1983 Apr;61(4):438-43
pubmed: 6828273
Obstet Gynecol. 2019 Feb;133(2):e97-e109
pubmed: 30681542
Obstet Gynecol. 2014 Jul;124(1):16-22
pubmed: 24901276
Int J Gynaecol Obstet. 2010 May;109(2):140-3
pubmed: 20129608
Cochrane Database Syst Rev. 2015 Jun 29;(6):CD001451
pubmed: 26121659
BMC Pregnancy Childbirth. 2015 Feb 10;15:22
pubmed: 25884884
Am J Obstet Gynecol. 2017 Jul;217(1):96-101
pubmed: 28389223
J Obstet Gynaecol. 2008 Oct;28(7):692-4
pubmed: 19065362
J Ultrasound Med. 2016 Aug;35(8):1725-33
pubmed: 27353072